register
log in
EN
change language
български
Čeština
Dansk
Deutsch
ελληνικά
English
Español
Eesti keel
Suomi
Français
Hrvatski
Magyar
Italiano
Lietuvių kalba
Latviešu valoda
Norsk
Nederlands
Polski
Português
Română
Pусский
Shqipja
Slovenský
Slovenščina
Svenska
Türkçe
Yкраїнська
change country
Albania
Argentina
Australia
Austria
Belgium
Bosnia & Herzegovina
Brazil
Bulgaria
Canada
Chile
Croatia
Cyprus
Czechia
Denmark
Estonia
European Union
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Montenegro
Netherlands
New Zealand
North Macedonia
Norway
Peru
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Türkiye
United Kingdom
United States
Start a petition
Petitions
Guidelines
About us
Help
Change language
български
Čeština
Dansk
Deutsch
ελληνικά
English
Español
Eesti keel
Suomi
Français
Hrvatski
Magyar
Italiano
Lietuvių kalba
Latviešu valoda
Norsk
Nederlands
Polski
Português
Română
Pусский
Shqipja
Slovenský
Slovenščina
Svenska
Türkçe
Yкраїнська
Change country
Albania
Argentina
Australia
Austria
Belgium
Bosnia & Herzegovina
Brazil
Bulgaria
Canada
Chile
Croatia
Cyprus
Czechia
Denmark
Estonia
European Union
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Montenegro
Netherlands
New Zealand
North Macedonia
Norway
Peru
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Türkiye
United Kingdom
United States
register
log in
Region: Portugal, Brasil, Angola, Moçambique, Cabo Verde
Welfare
A firma Agios tem de dar o Ivosidenib para o Maurice! A nossa última esperança!
Petitioner not public
Petition is directed to
Company Agios, USA
106,142
supporters
Petition process is finished
106,142
supporters
Petition process is finished
Launched 2017
Collection finished
Submitted
Dialogue
Finished
Petition
Pro & contra
News
Comments
No news update for this petition yet.
Help us to strengthen citizen participation. We want to support your petition to get the attention it deserves while remaining an independent platform.
Donate now
